LADENBURG THALM/SH SH Initiates Coverage on Crescent Capital BDC (NASDAQ:CCAP)

Analysts at LADENBURG THALM/SH SH assumed coverage on shares of Crescent Capital BDC (NASDAQ:CCAP) in a research report issued to clients and investors on Monday, MarketBeat.com reports. The brokerage set a “buy” rating and a $20.00 price target on the stock. LADENBURG THALM/SH SH’s target price points to a potential upside of 9.77% from the stock’s current price.

Several other equities analysts have also recently commented on CCAP. Wells Fargo & Company reduced their price objective on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 14th. Bank of America lowered their price objective on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, August 15th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Crescent Capital BDC presently has an average rating of “Moderate Buy” and an average target price of $19.00.

Crescent Capital BDC Stock Performance

NASDAQ CCAP opened at $18.22 on Monday. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.17. The company has a market capitalization of $675.27 million, a P/E ratio of 6.48 and a beta of 0.81. Crescent Capital BDC has a 12-month low of $15.03 and a 12-month high of $19.63. The firm has a 50-day moving average price of $18.36 and a two-hundred day moving average price of $18.17.

Crescent Capital BDC (NASDAQ:CCAP) last announced its quarterly earnings results on Monday, August 12th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.01. The firm had revenue of $48.95 million during the quarter, compared to analysts’ expectations of $48.05 million. Crescent Capital BDC had a net margin of 51.61% and a return on equity of 12.03%. During the same period in the prior year, the company posted $0.56 EPS. Analysts anticipate that Crescent Capital BDC will post 2.34 earnings per share for the current year.

Institutional Trading of Crescent Capital BDC

A number of large investors have recently made changes to their positions in the stock. Cubist Systematic Strategies LLC acquired a new position in shares of Crescent Capital BDC during the second quarter valued at about $346,000. Point72 Asset Management L.P. purchased a new stake in Crescent Capital BDC in the 2nd quarter valued at about $90,000. Millennium Management LLC raised its holdings in Crescent Capital BDC by 31.9% in the 2nd quarter. Millennium Management LLC now owns 268,097 shares of the company’s stock valued at $5,035,000 after buying an additional 64,902 shares during the period. Deerfield Management Company L.P. Series C purchased a new stake in Crescent Capital BDC in the 2nd quarter valued at about $1,021,000. Finally, Marshall Wace LLP purchased a new stake in Crescent Capital BDC in the 2nd quarter valued at about $767,000. 49.46% of the stock is owned by hedge funds and other institutional investors.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.